Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease

NCT03992469 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: EBFAHF-2
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai